インドでは475万人以上の患者を状血球貧血検査し,約180万人を診断しています. India screens over 4.75 crore people for sickle cell anemia, diagnosing nearly 1.8 million.
2023年7月に開始された"国家細胞貧血撲滅ミッション" (NSCAEM) 以来,インド17州で,1.98億人の部族の人々を含む約4.75億人が細胞貧血 (SCA) の検査を受けています. Around 4.75 crore people, including 1.98 crore tribal individuals, have been screened for sickle cell anemia (SCA) across 17 states in India since the National Sickle Cell Anaemia Elimination Mission (NSCAEM) launched in July 2023. 約180万人がSCAと診断され,12.54万人がキャリアとして特定されました. About 1.8 million people were diagnosed with SCA, while 12.54 lakh were identified as carriers. このミッションは,被災者の生活の質を向上させるため,カウンセリング,栄養支援,水酸化ユリア医薬品の利用等総合医療サービスを提供している. The mission offers comprehensive healthcare services, including counselling, nutritional support, and access to hydroxyurea medication, to improve the quality of life for those affected.